Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23008682 | 0.81 | TSHR (0.40) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL13609165 | 0.74 | TSHR (0.54) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL11095965 | 0.68 | CA2 (0.66) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL16918112 | 0.68 | USP2 (0.33) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL17321831 | 0.67 | BIRC2 (0.45) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL26992372 | 0.67 | HDAC8 (0.50) | USP2TSHRCA1CA2 | |
| SCHEMBL13499634 | 0.67 | HDAC8 (0.45) | TSHRCA1CA2 | |
| SCHEMBL15698018 | 0.66 | USP2 (0.40) | USP2TSHRCA1CA2ALDH1A1 | |
| SCHEMBL25978155 | 0.66 | MME (0.46) | USP2TSHRALDH1A1 | |
| SCHEMBL27285612 | 0.66 | TSHR (0.40) | USP2TSHRCA1CA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170304420-A1 | POLYMER ADJUVANT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170304420-A1 | POLYMER ADJUVANT | TLR3, TLR9, TLR1 | USP2 2464/4885TSHR 550/4885CA1 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.